State Street’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.3M Buy
1,349,539
+255,896
+23% +$2.89M ﹤0.01% 2334
2025
Q1
$12.6M Sell
1,093,643
-297,220
-21% -$3.43M ﹤0.01% 2383
2024
Q4
$11.8M Buy
1,390,863
+119,254
+9% +$1.01M ﹤0.01% 2532
2024
Q3
$14.7M Buy
1,271,609
+515,179
+68% +$5.97M ﹤0.01% 2379
2024
Q2
$8.91M Buy
756,430
+162,257
+27% +$1.91M ﹤0.01% 2627
2024
Q1
$7.05M Buy
594,173
+57,071
+11% +$677K ﹤0.01% 2770
2023
Q4
$6.58M Buy
537,102
+77,756
+17% +$953K ﹤0.01% 2814
2023
Q3
$4.42M Buy
459,346
+13,171
+3% +$127K ﹤0.01% 2977
2023
Q2
$4.02M Buy
446,175
+26,914
+6% +$242K ﹤0.01% 3101
2023
Q1
$3.3M Buy
419,261
+15,301
+4% +$120K ﹤0.01% 3145
2022
Q4
$2.73M Sell
403,960
-17,859
-4% -$121K ﹤0.01% 3280
2022
Q3
$6.12M Buy
421,819
+11,567
+3% +$168K ﹤0.01% 2961
2022
Q2
$4.04M Sell
410,252
-528,615
-56% -$5.2M ﹤0.01% 3198
2022
Q1
$13.8M Sell
938,867
-113,109
-11% -$1.67M ﹤0.01% 2642
2021
Q4
$13.9M Buy
1,051,976
+8,148
+0.8% +$108K ﹤0.01% 2712
2021
Q3
$18.2M Sell
1,043,828
-356,673
-25% -$6.22M ﹤0.01% 2539
2021
Q2
$33.6M Buy
1,400,501
+809,029
+137% +$19.4M ﹤0.01% 2137
2021
Q1
$15.2M Buy
591,472
+323,818
+121% +$8.32M ﹤0.01% 2522
2020
Q4
$5.08M Buy
267,654
+7,089
+3% +$135K ﹤0.01% 2950
2020
Q3
$3.28M Buy
260,565
+8,795
+3% +$111K ﹤0.01% 2994
2020
Q2
$3.05M Buy
251,770
+6,769
+3% +$81.9K ﹤0.01% 3004
2020
Q1
$1.87M Buy
245,001
+13,060
+6% +$99.9K ﹤0.01% 3089
2019
Q4
$4.13M Buy
231,941
+3,790
+2% +$67.5K ﹤0.01% 2925
2019
Q3
$2.65M Buy
228,151
+27,325
+14% +$317K ﹤0.01% 3115
2019
Q2
$4.45M Buy
200,826
+192,251
+2,242% +$4.26M ﹤0.01% 2894
2019
Q1
$245K Buy
+8,575
New +$245K ﹤0.01% 3549
2016
Q2
Sell
-7,820
Closed -$69K 3750
2016
Q1
$69K Sell
7,820
-2
-0% -$18 ﹤0.01% 3590
2015
Q4
$399K Hold
7,822
﹤0.01% 3377
2015
Q3
$394K Buy
7,822
+2,253
+40% +$113K ﹤0.01% 3375
2015
Q2
$557K Buy
+5,569
New +$557K ﹤0.01% 3354